Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
833
-
Total 13F shares, excl. options
-
50,916,680
-
Shares change
-
-8,841,139
-
Total reported value, excl. options
-
$7,666,252,840
-
Value change
-
-$1,332,296,824
-
Put/Call ratio
-
240%
-
Number of buys
-
359
-
Number of sells
-
-341
-
Price
-
$150.56
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2021
970 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q1 2021.
ISHARES TR - ISHARES BIOTECH (IBB) has 833 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50,916,680 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (13,541,539 shares), MORGAN STANLEY (6,066,382 shares), GOLDMAN SACHS GROUP INC (3,257,669 shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (2,660,000 shares), UBS Group AG (2,221,645 shares), CITIGROUP INC (2,185,916 shares), JPMORGAN CHASE & CO (2,063,758 shares), BNP PARIBAS ARBITRAGE, SA (1,563,414 shares), BARCLAYS PLC (1,207,552 shares), and ROYAL BANK OF CANADA (1,201,061 shares).
This table shows the top 833 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.